J Lundin Selected Research

Spinocerebellar ataxia 27

1/2020

Broader phenotypic traits and widespread brain hypometabolism in spinocerebellar ataxia 27.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Lundin Research Topics

Disease

12	Neoplasms (Cancer) 07/2015 - 11/2000
5	Breast Neoplasms (Breast Cancer) 12/2010 - 01/2001
4	Colorectal Neoplasms (Colorectal Cancer) 10/2011 - 01/2001
4	Stomach Neoplasms (Stomach Cancer) 09/2006 - 11/2000
4	Aneuploidy (Aneuploid) 09/2006 - 01/2001
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2011 - 12/2006
3	Carcinoma (Carcinomatosis) 11/2004 - 01/2001
3	Neoplasm Metastasis (Metastasis) 11/2004 - 11/2000
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2004 - 01/2003
2	Adenocarcinoma 11/2004 - 01/2001
1	Spinocerebellar ataxia 27 01/2020
1	Ataxia (Dyssynergia) 01/2020
1	Lymphadenopathy 10/2014
1	Infections 10/2014
1	Tongue Neoplasms (Tongue Neoplasm) 06/2011
1	Lung Neoplasms (Lung Cancer) 06/2011
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2009
1	Lymphoid Leukemia 07/2009
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 03/2007
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 03/2004
1	Trophoblastic Neoplasms (Trophoblastic Tumor) 01/2001
1	Lymphoma (Lymphomas) 01/2001
1	Lymphocytosis 01/2001
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2001
1	Disease Progression 01/2001
1	Leukemia 01/2001
1	Lymphatic Metastasis 11/2000

Drug/Important Bio-Agent (IBA)

5	Monoclonal AntibodiesIBA 03/2007 - 01/2001
4	AntigensIBA 11/2004 - 01/2001
3	Alemtuzumab (Campath)FDA Link 06/2011 - 12/2006
3	Syndecan-1 (Syndecan 1)IBA 01/2005 - 11/2000
3	Hormones (Hormone)IBA 01/2001 - 01/2001
2	IntegrinsIBA 01/2020 - 12/2010
2	Glycoproteins (Glycoprotein)IBA 01/2007 - 01/2001
2	TenascinIBA 01/2007 - 11/2004
2	Trypsin InhibitorsIBA 04/2005 - 01/2001
2	ParaffinIBA 11/2004 - 01/2001
2	Formaldehyde (Formol)FDA Link 11/2004 - 01/2001
2	Progesterone Receptors (Progesterone Receptor)IBA 11/2001 - 10/2001
2	DNA (Deoxyribonucleic Acid)IBA 11/2001 - 10/2001
2	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2001 - 01/2001
1	fibroblast growth factor 14IBA 01/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 07/2015
1	purineIBA 10/2014
1	Transcription Factors (Transcription Factor)IBA 10/2011
1	Oncogene Proteins (Oncogene Protein)IBA 06/2011
1	Indicators and Reagents (Reagents)IBA 06/2011
1	fludarabineIBA 06/2011
1	GlucocorticoidsIBA 07/2009
1	Dexamethasone (Maxidex)FDA LinkGeneric 07/2009
1	epoetin betaIBA 04/2007
1	IronIBA 04/2007
1	Hemoglobins (Hemoglobin)IBA 04/2007
1	Rituximab (Mabthera)FDA Link 03/2007
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2007
1	Tumor Biomarkers (Tumor Markers)IBA 01/2007
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2006
1	Xanthine DehydrogenaseIBA 09/2006
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2005
1	RNA (Ribonucleic Acid)IBA 11/2004
1	Coloring Agents (Dyes)IBA 01/2003
1	Proteins (Proteins, Gene)FDA Link 05/2001
1	Methotrexate (Mexate)FDA LinkGeneric 01/2001
1	Interleukin-4 (Interleukin 4)IBA 01/2001
1	CytokinesIBA 01/2001
1	Tissue Polypeptide AntigenIBA 01/2001
1	Fluorouracil (Carac)FDA LinkGeneric 01/2001
1	Estrogens (Estrogen)FDA Link 01/2001
1	Docetaxel (Taxotere)FDA Link 01/2001
1	Progesterone FDA LinkGeneric 01/2001
1	Peptides (Polypeptides)IBA 01/2001

Therapy/Procedure

5	Therapeutics 06/2011 - 01/2001
2	Drug Therapy (Chemotherapy) 04/2007 - 01/2001
1	Time-to-Treatment 10/2014
1	Splenectomy 03/2007